n(g)-iminoethylornithine has been researched along with 6-anilino-5,8-quinolinedione in 1 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (6-anilino-5,8-quinolinedione) | Trials (6-anilino-5,8-quinolinedione) | Recent Studies (post-2010) (6-anilino-5,8-quinolinedione) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 365 | 0 | 23 |
| Protein | Taxonomy | n(g)-iminoethylornithine (IC50) | 6-anilino-5,8-quinolinedione (IC50) |
|---|---|---|---|
| Guanylate cyclase soluble subunit beta-2 | Homo sapiens (human) | 1 | |
| Guanylate cyclase soluble subunit alpha-2 | Homo sapiens (human) | 1 | |
| Guanylate cyclase soluble subunit alpha-1 | Homo sapiens (human) | 1 | |
| Guanylate cyclase soluble subunit beta-1 | Homo sapiens (human) | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-Troya, S; Najib, S; Sánchez-Margalet, V | 1 |
1 other study(ies) available for n(g)-iminoethylornithine and 6-anilino-5,8-quinolinedione
| Article | Year |
|---|---|
eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Topics: Aminoquinolines; Animals; Arginine; Calcium; Carbazoles; Carcinoma, Hepatocellular; Cell Enlargement; Cell Proliferation; Chromogranin A; Chromogranins; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA; Enzyme Inhibitors; Guanylate Cyclase; Indoles; Isoenzymes; Leucine; Liver; MAP Kinase Signaling System; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Ornithine; Pancreatic Hormones; Peptides; Phospholipase C beta; Protein Isoforms; Rats; Receptors, Atrial Natriuretic Factor; Spermidine; Thymidine; Time Factors; Type C Phospholipases | 2005 |